Pfizer Lifts 2026 Revenue Outlook to $62B-$64B as Covid Sales Shrink
Pfizer's quarterly earnings and revenue came in above analyst forecasts, and the company lifted its full-year revenue range to $62 billion to $64 billion. CEO Albert Bourla says products other than Covid drove the result.
